With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.
Three top ASX shares that leading brokers have named as buys this week are listed below. Here's why they are bullish on them:
Image source: Getty Images
Boss Energy Ltd (ASX: BOE)
According to a note out of Bell Potter, its analysts have retained their buy rating and $2.90 price target on this uranium producer's shares. Bell Potter notes that there is a significant overhang currently, with its production beyond FY 2026 largely unknown following recent comments made in its guidance statement. And while it is yet to hear any further updates from management on this, Bell Potter suspects that management is working towards a solution or at least an update as to the path forward. As it stands, the broker is assuming production remains broadly in line with its FY 2026 guidance for FY 2027. As a result, it thinks there's plenty of value on offer here for investors. The Boss Energy share price is trading at $2.00 this afternoon.
Mesoblast Ltd (ASX: MSB)
Another note out of Bell Potter reveals that its analysts have retained their speculative buy rating and $3.50 price target on this biotechnology company's shares. This follows the release of an FY 2025 result that was in line with expectations. Outside this, the broker highlights that a major debt re-finance will be due in the coming months. However, there are multiple options available at far more commercial terms relative to the current extortionate rates it is paying from its pre revenue days. As a result, it does not expect a further equity raise and sees recent share price weakness as a buying opportunity. The Mesoblast share price is fetching $2.05 at the time of writing.
PEXA Group Ltd (ASX: PXA)
Analysts at Macquarie have retained their outperform rating on this property settlements technology company's shares with an improved price target of $17.30. According to the note, the broker was a touch disappointed with Pexa's FY 2025 results. However, it is looking beyond this and focusing on its medium term outlook. It highlights that the company is at a pivotal juncture, as a commitment from a second tier 1 lender could incentivise other large banks to quickly onboard, driving rapid market share gains. The Pexa share price is trading at $15.15 on Monday.
